Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Movement Disorders

• Publication date

  2016-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.26432PMID 26408291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.

  2014cited by this paper
• Parasomnias and isolated sleep symptoms in Parkinson's disease: a questionnaire study on 661 patients.

  2014cited by this paper
• Course of psychiatric symptoms and global cognition in early Parkinson disease

  2014cited by this paper
• Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

  2014cited by this paper
• Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4‐year study

  2013cited by this paper
• Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism.

  2013cited by this paper
• Parkinson's disease‐cognitive rating scale: Psychometrics for mild cognitive impairment

  2013cited by this paper
• Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease

  2012cited by this paper
• Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.

  2012cited by this paper
• Cerebral correlates of psychotic syndromes in neurodegenerative diseases

  2012cited by this paper
• Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study

  2012influential reference
• Psychosis in Parkinson's disease without dementia: Common and comorbid with other non‐motor symptoms

  2012influential reference
• Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression

  2011cited by this paper
• Feeling of presence in Parkinson's disease

  2011influential reference
• Epidemiology of psychosis in Parkinson's disease.

  2010influential reference
• A 12-year population-based study of psychosis in Parkinson disease.

  2010influential reference
• Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease

  2010cited by this paper
• Healthy individuals with auditory verbal hallucinations; who are they? Psychiatric assessments of a selected sample of 103 subjects.

  2010cited by this paper
• Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.

  2009cited by this paper
• Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.

  2009cited by this paper
• The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease

  2009cited by this paper
• Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania.

  2009cited by this paper
• Executive functions are impaired in patients with Parkinson’s disease with visual hallucinations

  2008cited by this paper
• Premotor Parkinson's disease: Clinical features, detection, and prospects for treatment

  2008influential reference
• Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms

  2008cited by this paper
• Cut‐off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease

  2008cited by this paper
• Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

  2008cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  2008cited by this paper
• Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease

  2008cited by this paper
• The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument

  2007influential reference
• A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations

  2007cited by this paper
• Cerebral atrophy in Parkinson's disease patients with visual hallucinations

  2007cited by this paper
• Hallucinations in Parkinson disease in the prelevodopa era

  2006cited by this paper
• Neuropsychological deficits in Parkinson's disease patients with visual hallucinations

  2006cited by this paper
• The malignant course of "benign hallucinations" in Parkinson disease.

  2006cited by this paper
• Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study.

  2005cited by this paper
• Hallucinations and sleep disorders in PD

  2005cited by this paper
• Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease

  2005influential reference
• The rarity of Charles Bonnet syndrome.

  2004cited by this paper
• Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

  2004cited by this paper
• Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table

  2004cited by this paper
• Ophthalmologic features of Parkinson’s disease

  2004cited by this paper
• Altered cortical visual processing in PD with hallucinations

  2004cited by this paper
• Dementia with Lewy bodies.

  2004cited by this paper
• Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom

  2004cited by this paper
• Ophthalmologic features of Parkinson's disease.

  2004cited by this paper
• Reality monitoring and visual hallucinations in Parkinson's disease.

  2003cited by this paper
• Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

  2002cited by this paper
• Prospective longitudinal assessment of hallucinations in Parkinson’s disease

  2001cited by this paper
• Prospective study of hallucinations and delusions in Parkinson's disease

  2001cited by this paper
• Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

  2000cited by this paper
• [Dementia with Lewy bodies].

  2000cited by this paper
• Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.

  1999cited by this paper
• A survey of delusional ideation in primary-care patients

  1998cited by this paper
• Mortality and hallucinations in nursing home patients with advanced Parkinson's disease

  1995cited by this paper
• Parkinson's disease: drug-induced psychiatric states.

  1995cited by this paper
• Bereavement among elderly people: grief reactions, post‐bereavement hallucinations and quality of life

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Distribution of hallucinations in the population

  1991cited by this paper
• Distributions of hallucinations in the population.

  1991cited by this paper
• Hallucinations of Widowhood

  1985cited by this paper
• The hallucinations of widowhood.

  1971cited by this paper
• Parkinsonism

  1967cited by this paper

• Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches.

  2026cites this paper
• Visual misperceptions in favour of living beings in Parkinson's disease: A psychophysical study.

  2026cites this paper
• Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs.

  2025cites this paper
• How Layer-Specific fMRI Can Contribute to Understanding Perceptual Disturbances Across Psychiatric Disorders.

  2025cites this paper
• Psychometric properties of the Italian version of scale for outcomes in Parkinson’s disease psychiatric complications in Parkinson disease

  2025cites this paper
• Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?

  2025cites this paper
• Clinical and Functional Connectivity Markers in Prediction of Hallucinations in Parkinson's Disease

  2025cites this paper
• Neuropsychiatric disorders in Parkinson’s disease

  2025cites this paper
• CBT for psychosis in Parkinson's disease: A framework for how and why.

  2025cites this paper
• Enhanced visual illusions in Parkinson’s disease with cardiovascular autonomic failure

  2025influential citation
• Hallucinations in Parkinson’s Disease: What They Really Look Like and How They Affect the Quality of Life

  2025cites this paper
• Association of the number of minor hallucinations and well-structured visual hallucinations in Parkinson’s disease

  2025cites this paper
• Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

  2025cites this paper
• Neuroimaging Advances in Neuropsychiatric Symptoms Associated with Parkinson’s Disease

  2025cites this paper
• Buried Treasure? Overlooked and Newly Discovered Evolutionary Contributions to Human Brain Diseases

  2025cites this paper
• Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial

  2025cites this paper
• Disrupted visual-to-semantic dynamics promote visual hallucinations in Parkinson’s disease

  2025influential citation
• Non-motor Symptoms and Treatments in Parkinson's Disease.

  2025cites this paper
• Approaches for treating neuropsychiatric symptoms in Parkinson’s disease: a narrative review

  2025cites this paper
• Metamorphopsia in a male with Parkinson disease - a giant problem?

  2025cites this paper
• Connectome-based brain fingerprints predict early cognitive decline in Parkinson’s patients with minor hallucinations

  2025cites this paper
• Reduced susceptibility to experimentally-induced complex visual hallucinations with age

  2025cites this paper
• Long‐Term Outcomes in a Parkinson's Disease Minor Phenomena Cohort

  2025influential citation
• A review on manganese and its effect on health and distribution in selected African countries.

  2025cites this paper
• Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s disease

  2024cites this paper
• Neuropsychiatric symptoms in Parkinson’s disease: review of data from the Arab world

  2024cites this paper
• Parkinson disease psychosis: from phenomenology to neurobiological mechanisms

  2024influential citation
• A general clinical overview of the non-motor symptoms in Parkinson's disease: Neuropsychiatric symptoms.

  2024cites this paper
• Exploring the Spectrum of Visual Illusions and Other Minor Hallucinations in Patients with Parkinson’s Disease in Lithuania

  2024influential citation
• Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

  2024cites this paper
• Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale.

  2024cites this paper
• Real-time fMRI neurofeedback modulates induced hallucinations and underlying brain mechanisms

  2024cites this paper
• Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem)

  2024cites this paper
• A New Definition of Psychosis Is Needed in Parkinson's Disease

  2024cites this paper
• On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis

  2024cites this paper
• Comorbilidad neurológica en pacientes psiquiátricos ingresados: evidencia sobre interconsultas de neurología en un centro español

  2024cites this paper
• Structural MRI study of Pareidolia and Visual Hallucinations in Drug–Naïve Parkinson’s disease

  2024cites this paper
• Contributions of Basal Ganglia Circuits to Perception, Attention, and Consciousness

  2024cites this paper
• Global research trends and hotspots in Parkinson’s disease psychosis: a 25-year bibliometric and visual analysis

  2024cites this paper
• Parkinson’s disease psychosis management: an evidence based, experience informed, pragmatic approach

  2024cites this paper
• Cognitive disorders in advanced Parkinson’s disease: challenges in the diagnosis of delirium

  2024cites this paper
• Numerosity estimation of virtual humans as a digital-robotic marker for hallucinations in Parkinson’s disease

  2024cites this paper
• Treatment Tactics for Psychosis in Parkinson’s Disease: A Literature Review

  2024cites this paper
• Clinical and cognitive features associated with psychosis in Parkinson's disease: a longitudinal study

  2024cites this paper
• To be or not to be hallucinating: Implications of hypnagogic/hypnopompic experiences and lucid dreaming for brain disorders

  2023cites this paper
• Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations

  2023cites this paper
• Visual Impairments in Parkinson’s Disease

  2023cites this paper
• Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease

  2023cites this paper
• Functional Brain Networks of Minor and Well‐Structured Major Hallucinations in Parkinson's Disease

  2023cites this paper
• Minor hallucinations in Parkinson’s disease with probable rapid eye movement sleep behavior disorder

  2023cites this paper
• Expectation Cues and False Percepts Generate Stimulus-Specific Activity in Distinct Layers of the Early Visual Cortex

  2023cites this paper
• Minor Phenomena in Parkinson’s Disease–Prevalence, Associations, and Risk of Developing Psychosis

  2023cites this paper
• Digital-robotic markers for hallucinations in Parkinson’s disease

  2023cites this paper
• Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature

  2023influential citation
• Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review

  2023cites this paper
• Clinical features of minor hallucinations in different phenotypes of Parkinson’s disease: A cross-sectional study

  2023influential citation
• Non-visual hallucinations in Parkinson’s disease: a systematic review

  2023cites this paper
• Perceptual expectations and false percepts generate stimulus-specific activity in distinct layers of the early visual cortex

  2023cites this paper
• Grey matter volume loss in Parkinson's Disease Psychosis and its relationship with serotonergic gene expression: A meta-analysis.

  2023cites this paper
• Neuropsychiatric features of Parkinson's disease in the era prior to the use of dopaminergic therapies

  2023cites this paper
• Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms

  2022cites this paper
• Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies

  2022cites this paper
• Sleep-related hallucinations in patients with Parkinson’s disease

  2022cites this paper
• Aberrant gray matter volume and functional connectivity in Parkinson’s disease with minor hallucination

  2022cites this paper
• Artificial intelligence-based clustering and characterization of Parkinson's disease trajectories

  2022cites this paper
• Incidence of antipsychotic use among community dwellers with and without Parkinson's disease.

  2022cites this paper
• [Visual disturbances in Parkinson's disease].

  2022cites this paper
• Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson’s Disease

  2022cites this paper
• Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.

  2022cites this paper
• A systematic review on resting state functional connectivity in patients with neurodegenerative disease and hallucinations

  2022cites this paper
• Theta oscillations and minor hallucinations in Parkinson’s disease reveal decrease in frontal lobe functions and later cognitive decline

  2022influential citation
• Motor and non-motor effects of apomorphine infusion

  2022cites this paper
• The role of attentional control over interference in minor hallucinations in Parkinson's disease.

  2022cites this paper
• Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study

  2022cites this paper
• Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson’s Disease

  2022cites this paper
• RNA-seq analysis of gene expression profiles in posttraumatic stress disorder, Parkinson’s disease and schizophrenia identifies roles for common and distinct biological pathways

  2022cites this paper
• Correlation between noise pareidolia test scores for visual hallucinations and regional cerebral blood flow in dementia with Lewy bodies

  2022cites this paper
• Allucinazioni e morbo di Parkinson

  2022cites this paper
• Clinical Characteristics of Minor Hallucinations in Chinese Parkinson's Disease Patients

  2022cites this paper
• Sleep and circadian rhythms in Parkinson’s disease and preclinical models

  2022cites this paper
• Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease

  2022cites this paper
• Cariprazina como alternativa farmacológica en el tratamiento de la psicosis en la enfermedad de Parkinson

  2022cites this paper
• The neuropsychiatry of Parkinson's disease: advances and challenges.

  2022cites this paper
• Parkinson's Disease With Visual Hallucinations Is Associated With Epileptiform Activity on EEG

  2022cites this paper
• Minor hallucinations in isolated rapid eye movement sleep behavior disorder indicative of early phenoconversion: A preliminary study

  2021cites this paper
• A transdiagnostic comparison of hallucinations

  2021cites this paper
• Neuropsychiatrische Störungen bei idiopathischem Parkinson-Syndrom

  2021cites this paper
• Frequency and Characteristics of Psychosis in Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2021cites this paper
• Halluzinationen bei Patienten mit idiopathischem Parkinson-Syndrom

  2021cites this paper
• Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson's Disease

  2021cites this paper
• Title Page Title: Apathy: an underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Running title: Apathy in prodromal Parkinson’s disease

  2021cites this paper
• Face Perception and Pareidolia Production in Patients With Parkinson's Disease

  2021cites this paper
• Psychosis

  2021cites this paper
• Ursachen visueller Halluzinationen bei der Parkinson-Krankheit

  2021cites this paper
• Knowledge domain and emerging trends in visual hallucination research: A scientometric analysis

  2021cites this paper
• Lewy Body Dementias: A Coin with Two Sides?

  2021cites this paper
• Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson’s disease

  2021cites this paper
• Visual hallucinations

  2021cites this paper
• QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review

  2021cites this paper
• Late life psychotic features in prodromal Parkinson's disease.

  2021cites this paper